Overview
Adi Abulafia practices in Jerusalem, Israel. Abulafia is rated as an Advanced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Their top areas of expertise are Astigmatism, Cataract, Keratoconus, Chronic Myelogenous Leukemia (CML), and Cataract Removal.
Their clinical research consists of co-authoring 76 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstigmatismAbulafia isElite. Learn about Astigmatism.
- CataractAbulafia isElite. Learn about Cataract.
- Cataract RemovalAbulafia isElite. Learn about Cataract Removal.
- Advanced
- Chronic Myelogenous Leukemia (CML)
- KeratoconusAbulafia isAdvanced. Learn about Keratoconus.
- NearsightednessAbulafia isAdvanced. Learn about Nearsightedness.
- Experienced
- Age-Related Macular Degeneration (ARMD)
- BlepharitisAbulafia isExperienced. Learn about Blepharitis.
- EndophthalmitisAbulafia isExperienced. Learn about Endophthalmitis.
- Gyrate Atrophy of the Choroid and Retina
- Late-Onset Retinal DegenerationAbulafia isExperienced. Learn about Late-Onset Retinal Degeneration.
- LeukemiaAbulafia isExperienced. Learn about Leukemia.